1. Ticagrelor was non-inferior to DAPT for the incidence of major adverse cardiovascular and cerebrovascular events. 2. Ticagrelor monotherapy significantly ...
1. Clinically relevant bleeding was significantly lower with ticagrelor monotherapy than in the ticagrelor plus aspirin group. 2. Major cardiovascular ...
1. Clinically relevant bleeding was significantly lower with ticagrelor monotherapy than in the ticagrelor plus aspirin group. 2. Major cardiovascular ...
1. Target-vessel failure was significantly lower in the ultrasound-guided group than the angiography-guided group. 2. There was no significant difference ...
1. Patients in the PCI group reported significantly lower rates of cardiac death, revascularization, and hospitalization than those in the ...
1. In this randomized controlled trial, complete revascularization reduced the risk of myocardial infarction, stroke, or ischemia-driven revascularization at one ...
![Reinnervation of cardiac infarcts decreases subsequent arrhythmia incidence [PreClinical]](https://www.2minutemedicine.com/wp-content/uploads/2015/02/1280px-Heart_ant_wall_infarction-350x250.jpg)
1. In this randomized controlled trial, complete revascularization reduced the risk of myocardial infarction, stroke, or ischemia-driven revascularization at one ...
1. In asymptomatic patients, subclinical coronary atherosclerosis was associated with an eight-fold elevated risk for myocardial infarction (MI). 2. Patients ...
1. A polypill consisting of aspirin, ramipril, and atorvastatin reduced the risk of major adverse cardiovascular events after a myocardial ...
1. Quantitative flow ratio (QFR) allowed for better periprocedural assessment of stenoses, leading to a lower amount of unnecessary stenting ...
